Lincoln Pharmaceuticals consolidated net profit rises 30.89% in the June 2026 quarter

Sales rise 15.06% to Rs 177.28 crore

Net profit of Lincoln Pharmaceuticals rose 30.89% to Rs 36.23 crore in the quarter ended June 2026 as against Rs 27.68 crore during the previous quarter ended June 2025. Sales rose 15.06% to Rs 177.28 crore in the quarter ended June 2026 as against Rs 154.07 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	177.28	154.07	15
OPM %	15.48	15.45	-
PBDT	51.44	38.87	32
PBT	47.55	35.39	34
NP	36.23	27.68	31

Powered by Capital Market - Live News